HEADER TRANSFERASE 16-AUG-03 1Q78 TITLE CRYSTAL STRUCTURE OF POLY(A) POLYMERASE IN COMPLEX WITH 3'-DATP AND TITLE 2 MAGNESIUM CHLORIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY(A) POLYMERASE ALPHA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-513; COMPND 5 SYNONYM: PAP, POLYNUCLEOTIDE ADENYLYLTRANSFERASE ALPHA; COMPND 6 EC: 2.7.7.19; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 GENE: PAPOLA OR PAP; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGM10 BOVPAP513 KEYWDS MRNA PROCESSING, NUCLEOTIDYL TRANSFERASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.MARTIN,A.MOGLICH,W.KELLER,S.DOUBLIE REVDAT 3 13-NOV-24 1Q78 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1Q78 1 VERSN REVDAT 1 07-SEP-04 1Q78 0 JRNL AUTH G.MARTIN,A.MOGLICH,W.KELLER,S.DOUBLIE JRNL TITL BIOCHEMICAL AND STRUCTURAL INSIGHTS INTO SUBSTRATE BINDING JRNL TITL 2 AND CATALYTIC MECHANISM OF MAMMALIAN POLY(A) POLYMERASE. JRNL REF J.MOL.BIOL. V. 341 911 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15328606 JRNL DOI 10.1016/J.JMB.2004.06.047 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 92.8 REMARK 3 NUMBER OF REFLECTIONS : 15770 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.400 REMARK 3 FREE R VALUE TEST SET COUNT : 1004 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.98 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 64.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1688 REMARK 3 BIN R VALUE (WORKING SET) : 0.3080 REMARK 3 BIN FREE R VALUE : 0.3400 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 113 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.032 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3796 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 123 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -7.23000 REMARK 3 B22 (A**2) : 8.98000 REMARK 3 B33 (A**2) : -1.76000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.39 REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.43 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.48 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.310 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.260 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.830 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.900 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 31.82 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : HETERO-CPDS-MR.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : HETERO-CPDS-MR.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q78 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-03. REMARK 100 THE DEPOSITION ID IS D_1000020003. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-AUG-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X12C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 15770 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.97 REMARK 200 COMPLETENESS FOR SHELL (%) : 64.4 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG8000, AMMONIUM SULFATE, MES BUFFER, REMARK 280 CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, PH 6, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 297K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.76000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 90.21000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.90500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 90.21000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.76000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.90500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 PHE A 3 REMARK 465 PRO A 4 REMARK 465 VAL A 5 REMARK 465 THR A 6 REMARK 465 THR A 7 REMARK 465 GLN A 8 REMARK 465 GLY A 9 REMARK 465 SER A 10 REMARK 465 GLN A 11 REMARK 465 GLN A 12 REMARK 465 THR A 13 REMARK 465 GLN A 14 REMARK 465 PRO A 15 REMARK 465 PRO A 16 REMARK 465 GLN A 17 REMARK 465 LYS A 18 REMARK 465 LYS A 445 REMARK 465 THR A 446 REMARK 465 GLU A 447 REMARK 465 ASN A 448 REMARK 465 SER A 449 REMARK 465 GLU A 450 REMARK 465 ASN A 451 REMARK 465 LEU A 452 REMARK 465 SER A 453 REMARK 465 VAL A 454 REMARK 465 SER A 499 REMARK 465 HIS A 500 REMARK 465 VAL A 501 REMARK 465 LEU A 502 REMARK 465 GLN A 503 REMARK 465 LYS A 504 REMARK 465 LYS A 505 REMARK 465 LYS A 506 REMARK 465 LYS A 507 REMARK 465 HIS A 508 REMARK 465 SER A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 GLY A 512 REMARK 465 VAL A 513 REMARK 465 LYS A 514 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 91 CG CD OE1 OE2 REMARK 470 LYS A 191 CG CD CE NZ REMARK 470 ASN A 192 CG OD1 ND2 REMARK 470 ASN A 294 CG OD1 ND2 REMARK 470 GLN A 343 CG CD OE1 NE2 REMARK 470 GLU A 409 CG CD OE1 OE2 REMARK 470 GLN A 419 CG CD OE1 NE2 REMARK 470 LYS A 430 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 84 7.66 48.67 REMARK 500 LEU A 85 151.13 -42.52 REMARK 500 THR A 131 -67.65 -124.59 REMARK 500 LEU A 146 98.78 -63.28 REMARK 500 ALA A 174 33.08 -73.41 REMARK 500 ASP A 186 107.49 -57.62 REMARK 500 ASN A 192 81.62 41.92 REMARK 500 SER A 238 107.62 176.63 REMARK 500 PHE A 243 -152.54 -109.80 REMARK 500 TYR A 260 58.35 -149.08 REMARK 500 LEU A 295 154.04 -41.61 REMARK 500 ASN A 296 76.05 -111.37 REMARK 500 ASP A 301 96.70 -170.86 REMARK 500 PHE A 368 7.67 -69.93 REMARK 500 PRO A 418 3.34 -58.10 REMARK 500 PHE A 421 163.55 178.79 REMARK 500 ASN A 427 106.23 176.49 REMARK 500 ASP A 429 -90.35 -80.11 REMARK 500 PHE A 433 79.36 -110.36 REMARK 500 ASP A 480 6.64 81.91 REMARK 500 LEU A 497 -93.06 -133.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1002 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 113 OD1 REMARK 620 2 ASP A 115 OD2 109.3 REMARK 620 3 3AT A1000 O1B 156.1 73.0 REMARK 620 4 3AT A1000 O3B 122.5 123.1 50.1 REMARK 620 5 3AT A1000 O5' 139.6 76.9 64.3 78.4 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 3AT A 1000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q79 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAMMALIAN POLY(A) POLYMERASE DBREF 1Q78 A 1 514 UNP P25500 PAPOA_BOVIN 0 513 SEQADV 1Q78 CSD A 36 UNP P25500 CYS 35 MODIFIED RESIDUE SEQADV 1Q78 CSD A 197 UNP P25500 CYS 196 MODIFIED RESIDUE SEQRES 1 A 514 MET PRO PHE PRO VAL THR THR GLN GLY SER GLN GLN THR SEQRES 2 A 514 GLN PRO PRO GLN LYS HIS TYR GLY ILE THR SER PRO ILE SEQRES 3 A 514 SER LEU ALA ALA PRO LYS GLU THR ASP CSD LEU LEU THR SEQRES 4 A 514 GLN LYS LEU VAL GLU THR LEU LYS PRO PHE GLY VAL PHE SEQRES 5 A 514 GLU GLU GLU GLU GLU LEU GLN ARG ARG ILE LEU ILE LEU SEQRES 6 A 514 GLY LYS LEU ASN ASN LEU VAL LYS GLU TRP ILE ARG GLU SEQRES 7 A 514 ILE SER GLU SER LYS ASN LEU PRO GLN SER VAL ILE GLU SEQRES 8 A 514 ASN VAL GLY GLY LYS ILE PHE THR PHE GLY SER TYR ARG SEQRES 9 A 514 LEU GLY VAL HIS THR LYS GLY ALA ASP ILE ASP ALA LEU SEQRES 10 A 514 CYS VAL ALA PRO ARG HIS VAL ASP ARG SER ASP PHE PHE SEQRES 11 A 514 THR SER PHE TYR ASP LYS LEU LYS LEU GLN GLU GLU VAL SEQRES 12 A 514 LYS ASP LEU ARG ALA VAL GLU GLU ALA PHE VAL PRO VAL SEQRES 13 A 514 ILE LYS LEU CYS PHE ASP GLY ILE GLU ILE ASP ILE LEU SEQRES 14 A 514 PHE ALA ARG LEU ALA LEU GLN THR ILE PRO GLU ASP LEU SEQRES 15 A 514 ASP LEU ARG ASP ASP SER LEU LEU LYS ASN LEU ASP ILE SEQRES 16 A 514 ARG CSD ILE ARG SER LEU ASN GLY CYS ARG VAL THR ASP SEQRES 17 A 514 GLU ILE LEU HIS LEU VAL PRO ASN ILE ASP ASN PHE ARG SEQRES 18 A 514 LEU THR LEU ARG ALA ILE LYS LEU TRP ALA LYS ARG HIS SEQRES 19 A 514 ASN ILE TYR SER ASN ILE LEU GLY PHE LEU GLY GLY VAL SEQRES 20 A 514 SER TRP ALA MET LEU VAL ALA ARG THR CYS GLN LEU TYR SEQRES 21 A 514 PRO ASN ALA ILE ALA SER THR LEU VAL HIS LYS PHE PHE SEQRES 22 A 514 LEU VAL PHE SER LYS TRP GLU TRP PRO ASN PRO VAL LEU SEQRES 23 A 514 LEU LYS GLN PRO GLU GLU CYS ASN LEU ASN LEU PRO VAL SEQRES 24 A 514 TRP ASP PRO ARG VAL ASN PRO SER ASP ARG TYR HIS LEU SEQRES 25 A 514 MET PRO ILE ILE THR PRO ALA TYR PRO GLN GLN ASN SER SEQRES 26 A 514 THR TYR ASN VAL SER VAL SER THR ARG MET VAL MET VAL SEQRES 27 A 514 GLU GLU PHE LYS GLN GLY LEU ALA ILE THR ASP GLU ILE SEQRES 28 A 514 LEU LEU SER LYS ALA GLU TRP SER LYS LEU PHE GLU ALA SEQRES 29 A 514 PRO ASN PHE PHE GLN LYS TYR LYS HIS TYR ILE VAL LEU SEQRES 30 A 514 LEU ALA SER ALA PRO THR GLU LYS GLN ARG LEU GLU TRP SEQRES 31 A 514 VAL GLY LEU VAL GLU SER LYS ILE ARG ILE LEU VAL GLY SEQRES 32 A 514 SER LEU GLU LYS ASN GLU PHE ILE THR LEU ALA HIS VAL SEQRES 33 A 514 ASN PRO GLN SER PHE PRO ALA PRO LYS GLU ASN PRO ASP SEQRES 34 A 514 LYS GLU GLU PHE ARG THR MET TRP VAL ILE GLY LEU VAL SEQRES 35 A 514 PHE LYS LYS THR GLU ASN SER GLU ASN LEU SER VAL ASP SEQRES 36 A 514 LEU THR TYR ASP ILE GLN SER PHE THR ASP THR VAL TYR SEQRES 37 A 514 ARG GLN ALA ILE ASN SER LYS MET PHE GLU VAL ASP MET SEQRES 38 A 514 LYS ILE ALA ALA MET HIS VAL LYS ARG LYS GLN LEU HIS SEQRES 39 A 514 GLN LEU LEU PRO SER HIS VAL LEU GLN LYS LYS LYS LYS SEQRES 40 A 514 HIS SER THR GLU GLY VAL LYS MODRES 1Q78 CSD A 36 CYS 3-SULFINOALANINE MODRES 1Q78 CSD A 197 CYS 3-SULFINOALANINE HET CSD A 36 8 HET CSD A 197 8 HET MG A1002 1 HET 3AT A1000 30 HETNAM CSD 3-SULFINOALANINE HETNAM MG MAGNESIUM ION HETNAM 3AT 3'-DEOXYADENOSINE-5'-TRIPHOSPHATE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE HETSYN 3AT CORDYCEPIN TRIPHOSPHATE FORMUL 1 CSD 2(C3 H7 N O4 S) FORMUL 2 MG MG 2+ FORMUL 3 3AT C10 H16 N5 O12 P3 FORMUL 4 HOH *123(H2 O) HELIX 1 1 LYS A 32 LYS A 47 1 16 HELIX 2 2 PRO A 48 GLY A 50 5 3 HELIX 3 3 GLU A 54 LYS A 83 1 30 HELIX 4 4 PRO A 86 GLU A 91 1 6 HELIX 5 5 GLY A 101 GLY A 106 1 6 HELIX 6 6 ASP A 125 PHE A 130 1 6 HELIX 7 7 THR A 131 LEU A 139 1 9 HELIX 8 8 ASP A 186 LYS A 191 5 6 HELIX 9 9 ASP A 194 LEU A 211 1 18 HELIX 10 10 ASN A 216 HIS A 234 1 19 HELIX 11 11 GLY A 245 LEU A 259 1 15 HELIX 12 12 ILE A 264 SER A 277 1 14 HELIX 13 13 ASN A 305 HIS A 311 5 7 HELIX 14 14 SER A 330 LEU A 353 1 24 HELIX 15 15 GLU A 357 GLU A 363 5 7 HELIX 16 16 ASN A 366 LYS A 370 5 5 HELIX 17 17 THR A 383 ASN A 408 1 26 HELIX 18 18 LEU A 456 SER A 474 1 19 HELIX 19 19 ARG A 490 HIS A 494 1 5 SHEET 1 A 5 LYS A 96 PHE A 100 0 SHEET 2 A 5 ILE A 114 ALA A 120 -1 O LEU A 117 N PHE A 98 SHEET 3 A 5 ILE A 164 ARG A 172 1 O LEU A 169 N ALA A 116 SHEET 4 A 5 VAL A 156 PHE A 161 -1 N LEU A 159 O ILE A 166 SHEET 5 A 5 VAL A 143 VAL A 149 -1 N ARG A 147 O LYS A 158 SHEET 1 B 3 ILE A 411 VAL A 416 0 SHEET 2 B 3 PHE A 433 PHE A 443 -1 O GLY A 440 N HIS A 415 SHEET 3 B 3 PHE A 421 PRO A 422 -1 N PHE A 421 O MET A 436 SHEET 1 C 4 ILE A 411 VAL A 416 0 SHEET 2 C 4 PHE A 433 PHE A 443 -1 O GLY A 440 N HIS A 415 SHEET 3 C 4 HIS A 373 ALA A 381 -1 N ILE A 375 O ILE A 439 SHEET 4 C 4 LYS A 482 LYS A 489 -1 O ALA A 484 N LEU A 378 LINK C ASP A 35 N CSD A 36 1555 1555 1.33 LINK C CSD A 36 N LEU A 37 1555 1555 1.33 LINK C ARG A 196 N CSD A 197 1555 1555 1.33 LINK C CSD A 197 N ILE A 198 1555 1555 1.33 LINK OD1 ASP A 113 MG MG A1002 1555 1555 2.99 LINK OD2 ASP A 115 MG MG A1002 1555 1555 2.54 LINK O1B 3AT A1000 MG MG A1002 1555 1555 3.04 LINK O3B 3AT A1000 MG MG A1002 1555 1555 2.74 LINK O5' 3AT A1000 MG MG A1002 1555 1555 3.15 CISPEP 1 TRP A 281 PRO A 282 0 0.24 CISPEP 2 TYR A 320 PRO A 321 0 -0.21 SITE 1 AC1 3 ASP A 113 ASP A 115 3AT A1000 SITE 1 AC2 18 PHE A 100 GLY A 101 SER A 102 ASP A 115 SITE 2 AC2 18 ASN A 202 VAL A 206 LYS A 228 TYR A 237 SITE 3 AC2 18 GLY A 246 VAL A 247 THR A 317 MG A1002 SITE 4 AC2 18 HOH A2043 HOH A2050 HOH A2060 HOH A2069 SITE 5 AC2 18 HOH A2108 HOH A2117 CRYST1 57.520 63.810 180.420 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017385 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015672 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005543 0.00000